BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28054931)

  • 1. Life expectancy after initiation of combination antiretroviral therapy in Thailand.
    Teeraananchai S; Chaivooth S; Kerr SJ; Bhakeecheep S; Avihingsanon A; Teeraratkul A; Sirinirund P; Law MG; Ruxrungtham K
    Antivir Ther; 2017; 22(5):393-402. PubMed ID: 28054931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
    Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
    Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 10-year effectiveness of combination antiretroviral treatment in perinatally HIV-infected children participating in Thailand's National Access Program.
    Aurpibul L; Puthanakit T; Sudjaritruk T; Oberdorfer P; Chotecharoentanan T; Taejaroenkul S; Wongnum N; Sirisanthana V
    Antivir Ther; 2016; 21(3):261-5. PubMed ID: 26158783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):772-81. PubMed ID: 27030657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
    Teeraananchai S; Kerr SJ; Amin J; Ruxrungtham K; Law MG
    HIV Med; 2017 Apr; 18(4):256-266. PubMed ID: 27578404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
    Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
    Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study.
    Teeraananchai S; Kerr SJ; Khananuraksa P; Ruxrungtham K; Puthanakit T
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25574. PubMed ID: 32869537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet HIV; 2017 Aug; 4(8):e349-e356. PubMed ID: 28501495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.
    Gueler A; Moser A; Calmy A; Günthard HF; Bernasconi E; Furrer H; Fux CA; Battegay M; Cavassini M; Vernazza P; Zwahlen M; Egger M;
    AIDS; 2017 Jan; 31(3):427-436. PubMed ID: 27831953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
    Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
    PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
    Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
    Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.
    Han WM; Apornpong T; Kerr SJ; Hiransuthikul A; Gatechompol S; Do T; Ruxrungtham K; Avihingsanon A
    AIDS Res Ther; 2018 Sep; 15(1):13. PubMed ID: 30261902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    ; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
    PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.
    Trickey A; Sabin CA; Burkholder G; Crane H; d'Arminio Monforte A; Egger M; Gill MJ; Grabar S; Guest JL; Jarrin I; Lampe FC; Obel N; Reyes JM; Stephan C; Sterling TR; Teira R; Touloumi G; Wasmuth JC; Wit F; Wittkop L; Zangerle R; Silverberg MJ; Justice A; Sterne JAC
    Lancet HIV; 2023 May; 10(5):e295-e307. PubMed ID: 36958365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
    McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
    PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss to follow-up and associated factors of patients in the National AIDS Program in Thailand.
    Teeraananchai S; Kerr SJ; Ruxrungtham K; Avihingsanon A; Chaivooth S; Teeraratkul A; Bhakeecheep S; Ongwandee S; Thanprasertsuk S; Law MG
    Antivir Ther; 2018; 23(6):529-538. PubMed ID: 29583122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of antiretroviral therapy initiation and treatment outcomes for people living with HIV in Vietnam.
    Tran DA; Shakeshaft A; Ngo AD; Mallitt KA; Wilson D; Doran C; Zhang L
    HIV Clin Trials; 2013; 14(1):21-33. PubMed ID: 23372112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.